ZYME Zymeworks Inc. - Common Stock
$27,70
Preço · Ago 19, 2026
Fundamentais a partir de Ago 6, 2026
Intervalo 52 Semanas
$13–$30
87% of range
Classificação do Analista
BUY
18 analysts
Preço-Alvo
$40
+46% upside
P/E (TTM)
-25.6
ROE
-26.9%
Margem de Lucro Líquido
-76.6%
Sobre Zymeworks Inc. - Common Stock Visão geral da empresa da Wikipedia
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
Ler mais
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year. In May 2017, Zymeworks held an IPO on the Toronto Stock Exchange, raising $59 million. This was the largest Canadian biotech IPO in more than a decade. By alphabetical order, Zymeworks is the last company on the Toronto Stock Exchange.
In May 2019, Zymeworks announced that GSK has expanded its 2016 licensing and collaboration agreement for the research, development and commercialization of bispecific antibodies across multiple disease areas. The extended agreement has meant that GSK can have access to Zymeworks' heavy-light chain pairing technology, which enables the development of bispecific and multifunctional therapeutics.
In September 2019, Zymeworks announced that, following their clinical trials, it has been confirmed that their ZW25 monotherapy can provide durable disease control in patients with a variety of HER2-expressing solid tumors that have progressed following standard of care treatments.
In May 2022, Zymeworks rejected an unsolicited takeover proposal from a Dubai hedge fund, All Blue Falcons FZE, an arm of All Blue Capital.
Azymetric
This is an IgG1-based heterodimeric antibody scaffold that consists of two different heavy chains engineered to exclusively assemble into a single molecule, allowing bi-specific binding to two different antigens or drug targets. The Azymetric scaffold is engineered by making amino acid changes in the CH3 region of the constant Fc domain of the IgG1. This scaffold can also be engineered with tailored effector function and optimized serum half-life.
Awards and recognition
Deal of the Year, Lifesciences BC Awards, 2018
Life Sciences Company of the Year, Lifesciences BC Awards, 2016
Emerging company of the year – Health, BIOTECanada Gold Leaf Awards, 2015
12th Place, BC's Leading Innovators, 2011
Life Science Emerging Rocket, 2009, 2010, 2011
Early stage Company of the year – Industrial & Agriculture, BIOTECanada Gold Leaf Awards, 2009
== References ==
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
ZYME Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$27.70
Capitalização de Mercado
$2.07B
P/E (TTM)
-25.6
EPS (TTM)
$-1.08
Receita (TTM)
$106M
Rendimento div.
—
ROE
-26.9%
Dívida/Capital
—
Intervalo 52 Semanas
$13 – $30
ZYME Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$106M
2020-12-31
→
2025-12-31
EPS
$-1.08
2020-12-31
→
2025-12-31
Fluxo de caixa livre
$-35M
2023-12-31
→
2025-12-31
Margens
-76.6%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
ZYME
Mediana de Pares
P/E (TTM)
-25.6
—
P/S (TTM)
19.5
418.4
P/B
7.7
2.3
Price / FCF (Preço / FCF)
-59.9
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
ZYME
Mediana de Pares
Operating Margin (Margem Operacional)
-87.3%
—
Net Profit Margin (Margem de Lucro Líquido)
-76.6%
-549.8%
ROA
-20.0%
-41.8%
ROE
-26.9%
-54.1%
ROIC
-35.1%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
ZYME
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
5.9
12.6
Quick Ratio (Índice de Liquidez Seca)
1.1
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
ZYME
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
38.9%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-36.4%
—
Revenue CAGR 5Y (CAGR Receita 5A)
22.2%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
ZYME
Mediana de Pares
ZYME Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
18 analistas
- Compra forte 6 33,3%
- Compra 11 61,1%
- Manter 1 5,6%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
12 analistas · 2026-08-16
Mediana
$38.50
← Abaixo de todos os alvos
$27.70
Mín
$31.00
Máx
$58.00
Alvo mediano
$38.50
+39,0%
Alvo médio
$40.33
+45,6%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.01%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.62 | $-0.50 | -0.12% |
| 31 de Março de 2026 | $-0.59 | $-0.20 | -0.39% |
| 31 de Dezembro de 2025 | $-0.55 | $-0.42 | -0.13% |
| 30 de Setembro de 2025 | $-0.26 | $-0.33 | 0.07% |
| 30 de Junho de 2025 | $0.03 | $-0.50 | 0.53% |
| 31 de Março de 2025 | $-0.30 | $-0.42 | 0.12% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| AUPH | $2.11B | 7.7 | 20.4% | 101.5% | 62.7% | — |
| ABUS | $926M | -28.3 | 128.2% | -237.9% | -42.0% | — |
| ACOG | $141M | -5.5 | — | -202.2% | -43.8% | — |
| PMN | $15M | -0.3 | — | — | 4840.3% | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $106M | $76M | $76M | $412M | $27M | |
| R&D Expense | · | · | $144M | $209M | $200M | |
| SG&A Expense | $62M | $62M | $70M | $73M | $43M | |
| Operating Expenses | $199M | $213M | $214M | $282M | $242M | |
| Operating Income | $-93M | $-137M | $-138M | $131M | $-216M | |
| Other Non-op | $51.0K | $-218.0K | $291.0K | $-42.0K | $118.0K | |
| Pretax Income | $-80M | $-117M | $-119M | $135M | $-212M | |
| Income Tax | $1M | $6M | $-568.0K | $11M | $-516.0K | |
| Net Income | $-81M | $-123M | $-119M | $124M | $-212M | |
| EPS (Basic) | $-1.08 | $-1.62 | $-1.72 | $1.91 | $-4.11 | |
| EPS (Diluted) | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 | |
| Shares (Basic) | 75,404,897 | 75,846,681 | 68,863,010 | 65,194,775 | 51,553,869 | |
| Shares (Diluted) | 75,413,396 | 75,878,738 | 68,863,010 | 65,249,184 | 52,131,596 | |
| EBITDA | $-93M | $-137M | $-138M | · | · |
Balanço Patrimonial 23
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $66M | $158M | $401M | $202M | |
| Short-term Investments | · | · | $217M | $91M | $51M | |
| Receivables | $5M | $56M | $19M | $33M | $16M | |
| Prepaid Expense | $15M | $19M | $19M | $19M | $20M | |
| Current Assets | $249M | $300M | $413M | $545M | $288M | |
| PP&E (Net) | $16M | $18M | $20M | $25M | $23M | |
| PP&E (Gross) | $36M | $35M | $41M | $38M | $37M | |
| Accum. Depreciation | $21M | $18M | $21M | $13M | $14M | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | |
| Intangibles | $1M | $5M | $8M | $9M | $4M | |
| Total Assets | $347M | $463M | $581M | $649M | $389M | |
| Accounts Payable | $36M | $60M | $46M | $87M | $63M | |
| Current Liabilities | $42M | $88M | $56M | $96M | $72M | |
| Capital Leases | $15M | $16M | $22M | $25M | $31M | |
| Deferred Tax | $6M | $5M | $3M | $2M | $2M | |
| Other Non-current Liabilities | $278.0K | $923.0K | $2M | $3M | $3M | |
| Total Liabilities | $78M | $124M | $116M | $156M | $140M | |
| Common Stock | $1.11B | $1.02B | $997M | $886M | $741M | |
| Retained Earnings | $-953M | $-830M | $-677M | $-559M | $-683M | |
| AOCI | $-6M | $-7M | $-7M | $-7M | $-7M | |
| Stockholders' Equity | $269M | $339M | $465M | $493M | $249M | |
| Liabilities + Equity | $347M | $463M | $581M | $649M | $389M | |
| Shares Outstanding | 74,638,413 | 68,964,319 | 70,115,997 | 63,059,501 | 46,633,935 |
Fluxo de Caixa 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $28M | $18M | $8M | $4M | $11M | |
| Deferred Tax | $945.0K | $691.0K | $-757.0K | $2M | $-953.0K | |
| Amort. of Intangibles | $4M | $4M | $3M | $1M | $3M | |
| Restructuring | · | · | $0 | · | · | |
| Operating Cash Flow | $-33M | $-110M | $-118M | $144M | $-192M | |
| CapEx | $2M | $2M | $2M | $8M | $12M | |
| Investing Cash Flow | $27M | $39M | $-207M | $-54M | $145M | |
| Stock Issued | $0 | $0 | $26M | $108M | $0 | |
| Stock Repurchased | $42M | $30M | $0 | $0 | · | |
| Net Stock Activity | $-42M | $-30M | $26M | · | · | |
| Financing Cash Flow | $-19M | $-20M | $82M | $109M | $8M | |
| Net Change in Cash | $-25M | $-91M | $-243M | $199M | $-40M | |
| Taxes Paid | $1M | $3M | $165.0K | $10M | · | |
| Free Cash Flow | $-35M | $-112M | $-121M | · | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | -87.3% | -179.7% | -181.6% | · | · | |
| Net Margin | -76.6% | -160.8% | -156.1% | · | · | |
| Pretax Margin | -75.3% | -152.8% | -156.9% | · | · | |
| EBITDA Margin | -87.3% | -179.7% | -181.6% | · | · | |
| ROA | -20.0% | -23.5% | -19.3% | · | · | |
| ROE | -26.9% | -34.8% | -26.7% | · | · | |
| ROIC | -35.1% | -42.6% | -29.6% | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 3.4 | 7.4 | · | · | |
| Quick Ratio | 1.1 | 1.4 | 7.1 | · | · |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 3.5 | 2.0 | 2.9 | · | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 38.9% | 0.38% | -81.6% | 1446.0% | -31.5% | |
| Revenue CAGR 3Y | -36.4% | 41.9% | 25.0% | · | · | |
| Revenue CAGR 5Y | 22.2% | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $76M | $76M | $412M | · | |
| Net Income TTM | $-81M | $-123M | $-119M | $124M | · | |
| Market Cap | $1.97B | $1.01B | $729M | · | · | |
| P/E | -24.4 | -9.0 | -6.0 | 4.1 | · | |
| P/S | 18.5 | 13.2 | 9.6 | · | · | |
| P/B | 7.3 | 3.0 | 1.6 | · | · | |
| P / Tangible Book | 7.7 | 3.1 | 1.6 | 1.0 | · | |
| P / Cash Flow | -59.5 | -9.2 | -6.2 | · | · | |
| P / FCF | -56.9 | -9.0 | -6.0 | · | · | |
| Earnings Yield | -4.1% | -11.1% | -16.6% | 24.2% | · |
Demonstração de Resultados 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $2M | $3M | $28M | $49M | $27M | $31M | $16M | $19M | $10M | $17M | $17M | $7M | $36M | $402M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | $32M | · | $33M | $39M | $46M | · | $37M | |
| SG&A Expense | $19M | $15M | $15M | $14M | $15M | $17M | $16M | $14M | $16M | $16M | $15M | $17M | $22M | $17M | $30M | $16M | |
| Operating Expenses | $47M | $50M | $47M | $50M | $49M | $53M | $53M | $50M | $62M | $48M | $40M | $50M | $61M | $63M | $83M | $53M | |
| Operating Income | $-42M | $-47M | $-44M | $-22M | $-674.0K | $-26M | $-22M | $-34M | $-43M | $-38M | $-23M | $-33M | $-54M | $-27M | $319M | $-50M | |
| Other Non-op | $196.0K | $120.0K | $-18.0K | $26.0K | $-621.0K | $49.0K | $-253.0K | $-37.0K | $53.0K | $19.0K | $-278.0K | $370.0K | $230.0K | $-31.0K | $-27.0K | $-98.0K | |
| Pretax Income | $-45M | $-46M | $-41M | $-18M | $2M | $-22M | $-18M | $-30M | $-38M | $-32M | $-19M | $-28M | $-49M | $-23M | $320M | $-48M | |
| Income Tax | $-273.0K | $-2M | $-270.0K | $1M | $-186.0K | $496.0K | $6M | $226.0K | $68.0K | $75.0K | $-5M | $1M | $2M | $1M | $11M | $-29.0K | |
| Net Income | $-45M | $-44M | $-41M | $-20M | $2M | $-23M | $-24M | $-30M | $-38M | $-32M | $-14M | $-29M | $-51M | $-24M | $309M | $-48M | |
| EPS (Basic) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.19 | $-0.41 | $-0.76 | $-0.36 | $4.78 | $-0.72 | |
| EPS (Diluted) | $-0.62 | $-0.59 | $-0.55 | $-0.26 | $0.03 | $-0.30 | $-0.32 | $-0.39 | $-0.49 | $-0.42 | $-0.18 | $-0.41 | $-0.76 | $-0.37 | $4.78 | $-0.72 | |
| Shares (Basic) | 72,993,313 | 74,668,790 | -150,871,069 | 75,767,778 | 75,337,168 | 75,171,020 | -152,889,276 | 76,128,531 | 76,392,593 | 76,214,833 | -135,733,099 | 70,575,773 | 67,281,028 | 66,739,308 | -129,002,888 | 66,477,016 | |
| Shares (Diluted) | 72,993,313 | 74,694,762 | -152,966,654 | 75,775,214 | 77,378,449 | 75,226,387 | -152,922,738 | 76,157,101 | 76,396,217 | 76,248,158 | -135,739,304 | 70,575,773 | 67,284,511 | 66,742,030 | -128,961,927 | 66,478,157 | |
| EBITDA | $-42M | $-47M | · | $-22M | $-674.0K | $-26M | · | $-34M | $-43M | $-38M | · | $-33M | $-54M | $-27M | · | $-50M |
Balanço Patrimonial 23
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $179M | $244M | $41M | $65M | $98M | $76M | $66M | $122M | $71M | $115M | · | $94M | $142M | $182M | · | $96M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $201M | $198M | $159M | · | $70M | |
| Receivables | $6M | $5M | $5M | $29M | $3M | $25M | $56M | $24M | $32M | $31M | · | $67M | $49M | $67M | · | $7M | |
| Prepaid Expense | $22M | $16M | $15M | $10M | $12M | $17M | $19M | $23M | $21M | $18M | · | $12M | $31M | $19M | · | $18M | |
| Current Assets | $298M | $386M | $249M | $292M | $296M | $306M | $300M | $344M | $383M | $394M | · | $375M | $420M | $426M | · | $191M | |
| PP&E (Net) | $14M | $15M | $16M | $16M | $16M | $17M | $18M | $18M | $18M | $19M | · | $21M | $22M | $24M | · | $26M | |
| PP&E (Gross) | · | · | $36M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $21M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Intangibles | $998.0K | $1M | $1M | $1M | $2M | $3M | $5M | $6M | $7M | $7M | · | $8M | $7M | $8M | · | $9M | |
| Total Assets | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Accounts Payable | $27M | $30M | $36M | $34M | $31M | $38M | $60M | $52M | $44M | $47M | · | $68M | $70M | $59M | · | $52M | |
| Current Liabilities | $47M | $36M | $42M | $42M | $39M | $65M | $88M | $84M | $55M | $57M | · | $73M | $94M | $67M | · | $58M | |
| Capital Leases | $13M | $14M | $15M | $16M | $15M | $15M | $16M | $17M | $17M | $21M | · | $22M | $23M | $24M | · | $25M | |
| Deferred Tax | $4M | $4M | $6M | $5M | $5M | $5M | $5M | $3M | $3M | $3M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $278.0K | $278.0K | $278.0K | $278.0K | $828.0K | $856.0K | $923.0K | $929.0K | $1M | $2M | · | $2M | $4M | $4M | · | $3M | |
| Total Liabilities | $317M | $315M | $78M | $77M | $74M | $101M | $124M | $120M | $109M | $116M | · | $132M | $153M | $127M | · | $121M | |
| Common Stock | $1.13B | $1.13B | $1.11B | $1.09B | $1.07B | $1.02B | $1.02B | $1.01B | $1.01B | $1.00B | · | $932M | $929M | $900M | · | $885M | |
| Retained Earnings | $-1.17B | $-1.07B | $-953M | $-886M | $-851M | $-853M | $-830M | $-798M | $-747M | $-709M | · | $-663M | $-634M | $-583M | · | $-868M | |
| AOCI | $-7M | $-7M | $-6M | $-6M | $-6M | $-6M | $-7M | $-6M | $-8M | $-8M | · | $-8M | $-8M | $-6M | · | $-7M | |
| Stockholders' Equity | $80M | $164M | $269M | $320M | $335M | $325M | $339M | $367M | $406M | $438M | $465M | $424M | $449M | $474M | $493M | $180M | |
| Liabilities + Equity | $397M | $478M | $347M | $397M | $408M | $426M | $463M | $487M | $516M | $554M | · | $556M | $602M | $601M | · | $300M | |
| Shares Outstanding | 71,412,072 | 73,102,689 | 74,638,413 | 75,139,281 | 74,846,147 | 69,584,811 | 68,964,319 | 69,584,882 | 70,831,545 | 70,677,106 | · | 67,922,559 | 67,687,384 | 64,083,770 | · | 61,694,387 |
Fluxo de Caixa 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $7M | $9M | $7M | $6M | $6M | $5M | $5M | $5M | $4M | $3M | $2M | $367.0K | $2M | $4M | $5M | |
| Amort. of Intangibles | $176.0K | $176.0K | $185.0K | $648.0K | $2M | $2M | $2M | $980.0K | $812.0K | $702.0K | $673.0K | $672.0K | $678.0K | $679.0K | $529.0K | $166.0K | |
| Operating Cash Flow | $-32M | $-46M | $-10M | $-31M | $12M | $-3M | $-42M | $-6M | $-25M | $-38M | $14M | $-43M | $-6M | $-83M | $327M | $-73M | |
| CapEx | $0 | $216.0K | $581.0K | $410.0K | $514.0K | $16.0K | $314.0K | $899.0K | $593.0K | $185.0K | $356.0K | $930.0K | $802.0K | $386.0K | $348.0K | $981.0K | |
| Investing Cash Flow | $17M | $70M | $5M | $368.0K | $9M | $12M | $-6M | $72M | $-20M | $-7M | $-1M | $-7M | $-61M | $-138M | $-22M | $-30M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | $26M | $0 | $0 | $0 | |
| Stock Repurchased | $52M | $76M | $25M | $16M | $0 | $0 | $9M | · | · | · | $0 | · | · | · | · | · | |
| Net Stock Activity | · | $-76M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-50M | $179M | $-19M | $-2M | $1M | $1M | $-9M | $-15M | $1M | $2M | $51M | $2M | $28M | $2M | $-377.0K | $628.0K | |
| Net Change in Cash | $-65M | $203M | $-24M | $-33M | $22M | $10M | $-56M | $51M | $-44M | $-43M | $63M | $-48M | $-39M | $-219M | $305M | $-103M | |
| Taxes Paid | $863.0K | $245.0K | $107.0K | $660.0K | $196.0K | $387.0K | $3M | $106.0K | $106.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-46M | · | · | · | $-3M | · | · | · | $-38M | · | · | · | $-84M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| Net Margin | -980.8% | -1834.0% | · | -71.0% | 4.8% | -83.5% | · | -186.6% | -195.8% | -315.6% | · | -173.8% | -730.5% | -68.5% | · | -1818.6% | |
| Pretax Margin | -986.8% | -1925.0% | · | -66.1% | 4.4% | -81.7% | · | -185.2% | -195.5% | -314.8% | · | -167.1% | -706.9% | -64.5% | · | -1819.7% | |
| EBITDA Margin | -919.0% | -1956.7% | · | -80.1% | -1.4% | -94.5% | · | -213.8% | -222.9% | -376.9% | · | -201.4% | -772.8% | -76.7% | · | -1914.0% | |
| ROA | -11.2% | -9.8% | · | -4.4% | 0.50% | -4.6% | · | -5.7% | -6.7% | -5.5% | · | -6.7% | -17.0% | -8.1% | · | -31.9% | |
| ROE | -21.7% | -18.1% | · | -5.7% | 0.63% | -5.9% | · | -7.5% | -8.8% | -6.9% | · | -9.5% | -22.8% | -10.3% | · | -53.2% | |
| ROIC | -52.2% | -27.4% | · | -7.4% | -0.22% | -8.1% | · | -9.4% | -10.6% | -8.6% | · | -8.2% | -12.5% | -6.1% | · | -28.0% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.3 | 10.8 | · | 6.9 | 7.7 | 4.7 | · | 4.1 | 7.0 | 6.9 | · | 5.1 | 4.5 | 6.3 | · | 3.3 | |
| Quick Ratio | 3.9 | 7.0 | · | 2.2 | 2.6 | 1.5 | · | 1.7 | 1.9 | 2.6 | · | 5.0 | 4.2 | 6.1 | · | 3.0 |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.2 | · | 1.0 | 2.8 | 1.0 | · | 0.4 | 0.5 | 0.2 | · | 0.4 | 0.3 | 1.1 | · | 0.8 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $83M | $106M | · | $119M | $111M | $72M | · | $62M | $53M | $69M | · | $62M | $51M | $46M | · | $14M | |
| Net Income TTM | $-106M | $-84M | · | $-70M | $-88M | $-122M | · | $-128M | $-149M | $-136M | · | $-152M | $-188M | $-209M | · | $-246M | |
| Market Cap | $1.87B | $1.83B | · | $1.28B | $939M | $829M | · | $873M | $603M | $744M | · | $431M | $585M | $579M | · | $379M | |
| P/E | -18.2 | -22.4 | · | -18.6 | -10.9 | -7.4 | · | -7.3 | -4.1 | -5.4 | · | -2.8 | -3.1 | -2.8 | · | -1.5 | |
| P/S | 22.4 | 17.3 | · | 10.7 | 8.5 | 11.4 | · | 14.1 | 11.4 | 10.8 | · | 7.0 | 11.5 | 12.7 | · | 26.4 | |
| P/B | 23.2 | 11.2 | · | 4.0 | 2.8 | 2.6 | · | 2.4 | 1.5 | 1.7 | · | 1.0 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 27.7 | 12.2 | · | 4.2 | 2.9 | 2.7 | · | 2.5 | 1.6 | 1.8 | · | 1.1 | 1.4 | 1.3 | · | 2.4 | |
| P / Cash Flow | · | -40.0 | · | · | · | -243.3 | · | · | · | -19.7 | · | · | · | -7.0 | · | · | |
| P / FCF | · | -39.9 | · | · | · | -242.1 | · | · | · | -19.6 | · | · | · | -6.9 | · | · | |
| Earnings Yield | -5.5% | -4.5% | · | -5.4% | -9.2% | -13.4% | · | -13.6% | -24.4% | -18.6% | · | -35.6% | -32.6% | -35.9% | · | -67.2% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $106M | $76M | $76M | $412M | $27M |
| Margem Operacional % | -87.3% | -179.7% | -181.6% | — | — |
| Lucro líquido | $-81M | $-123M | $-119M | $124M | $-212M |
| EPS Diluído | $-1.08 | $-1.62 | $-1.72 | $1.90 | $-4.61 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 5.9 | 3.4 | 7.4 | — | — |
| Índice de Liquidez Seca | 1.1 | 1.4 | 7.1 | — | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-35M | $-112M | $-121M | — | — |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 218 declarantes · $1.5B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 30 (-11 vs trimestre anterior) | 30 (-1 vs trimestre anterior) | 56 (-17 vs trimestre anterior) | 68 (+9 vs trimestre anterior) | +200K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| EcoR1 Capital, LLC | $600.445.942 | 22.970.388 | 39,27% | Ações |
| Rubric Capital Management LP | $182.980.000 | 7.000.000 | 11,97% | Ações |
| PERCEPTIVE ADVISORS LLC | $109.342.391 | 4.182.953 | 7,15% | Ações |
| BVF INC/IL | $95.388.572 | 3.649.142 | 6,24% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.752.208 | 1.558.998 | 2,67% | Ações |
| Assenagon Asset Management S.A. | $32.727.986 | 1.252.027 | 2,14% | Ações |
| Nextech Invest Ltd. | $29.118.548 | 1.113.946 | 1,90% | Ações |
| STATE STREET CORP | $28.445.966 | 1.088.216 | 1,86% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $24.486.776 | 936.755 | 1,60% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23.259.000 | 889.802 | 1,52% | Ações |
| CITADEL ADVISORS LLC | $21.330.894 | 816.025 | 1,40% | Ações |
| FMR LLC | $18.355.822 | 702.212 | 1,20% | Ações |
| Prosight Management, LP | $17.629.705 | 674.434 | 1,15% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $16.322.460 | 624.447 | 1,07% | Ações |
| Nextech Invest Ltd. | $16.308.169 | 1.113.946 | 1,07% | Ações |
| Qube Research & Technologies Ltd | $15.516.443 | 593.590 | 1,01% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.332.236 | 510.032 | 0,87% | Ações |
| Redmile Group, LLC | $12.851.836 | 491.654 | 0,84% | Ações |
| Capricorn Fund Managers Ltd | $12.717.868 | 486.529 | 0,83% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.939.512 | 418.497 | 0,72% | Ações |
| Hillsdale Investment Management Inc. | $10.009.581 | 382.922 | 0,65% | Ações |
| GOLDMAN SACHS GROUP INC | $9.345.338 | 357.511 | 0,61% | Ações |
| FIRST TRUST ADVISORS LP | $8.897.088 | 340.363 | 0,58% | Ações |
| Granahan Investment Management, LLC | $8.787.144 | 336.157 | 0,57% | Ações |
| Pictet Asset Management Holding SA | $7.446.189 | 308.187 | 0,49% | Ações |
| PICTON MAHONEY ASSET MANAGEMENT | $7.092.908 | 271.343 | 0,46% | Ações |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.849.243 | 223.766 | 0,38% | Ações |
| SummitTX Capital, L.P. | $5.510.364 | 210.802 | 0,36% | Ações |
| Man Group plc | $5.509.763 | 210.779 | 0,36% | Ações |
| BANK OF AMERICA CORP /DE/ | $5.182.437 | 198.257 | 0,34% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.066.835 | 155.579 | 0,27% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.984.154 | 152.416 | 0,26% | Ações |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.960.132 | 151.497 | 0,26% | Ações |
| KENNEDY CAPITAL MANAGEMENT LLC | $3.800.390 | 145.386 | 0,25% | Ações |
| D. E. Shaw & Co., Inc. | $3.785.255 | 144.807 | 0,25% | Ações |
| DIADEMA PARTNERS LP | $3.715.330 | 142.132 | 0,24% | Ações |
| BlackRock, Inc. | $3.614.744 | 138.284 | 0,24% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.408.656 | 130.400 | 0,22% | Opção de compra |
| CITIGROUP INC | $3.364.872 | 128.725 | 0,22% | Ações |
| XTX Topco Ltd | $3.290.425 | 125.877 | 0,22% | Ações |
| PANAGORA ASSET MANAGEMENT INC | $3.100.282 | 118.603 | 0,20% | Ações |
| PLATINUM INVESTMENT MANAGEMENT LTD | $2.749.510 | 105.184 | 0,18% | Ações |
| AXA Investment Managers S.A. | $2.705.745 | 158.416 | 0,18% | Ações |
| Manatuck Hill Partners, LLC | $2.614.000 | 100.000 | 0,17% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.451.932 | 93.800 | 0,16% | Opção de venda |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $2.321.232 | 88.800 | 0,15% | Ações |
| MACKENZIE FINANCIAL CORP | $2.293.654 | 87.745 | 0,15% | Ações |
| VANGUARD GROUP INC | $2.251.979 | 85.529 | 0,15% | Ações |
| Y-Intercept (Hong Kong) Ltd | $2.181.514 | 83.455 | 0,14% | Ações |
| LMR Partners LLP | $2.156.550 | 82.500 | 0,14% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $2.127.587 | 81.392 | 0,14% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $2.094.337 | 80.120 | 0,14% | Ações |
| TEMA ETFS LLC | $2.000.422 | 75.975 | 0,13% | Ações |
| RHUMBLINE ADVISERS | $1.962.211 | 75.066 | 0,13% | Ações |
| Swiss National Bank | $1.939.588 | 74.200 | 0,13% | Ações |
| MARTINGALE ASSET MANAGEMENT L P | $1.915.592 | 73.282 | 0,13% | Ações |
| TWO SIGMA INVESTMENTS, LP | $1.878.786 | 71.874 | 0,12% | Ações |
| Dana Investment Advisors, Inc. | $1.873.192 | 71.660 | 0,12% | Ações |
| CREDIT AGRICOLE S A | $1.855.940 | 71.000 | 0,12% | Ações |
| Fisher Asset Management, LLC | $1.850.057 | 70.775 | 0,12% | Ações |
| SEGALL BRYANT & HAMILL, LLC | $1.747.093 | 66.836 | 0,11% | Ações |
| Verdad Advisers, LP | $1.743.224 | 66.688 | 0,11% | Ações |
| Susquehanna Portfolio Strategies, LLC | $1.705.583 | 65.248 | 0,11% | Ações |
| Campbell & CO Investment Adviser LLC | $1.591.246 | 60.874 | 0,10% | Ações |
| ALLIANCEBERNSTEIN L.P. | $1.399.636 | 55.896 | 0,09% | Ações |
| CITADEL ADVISORS LLC | $1.364.508 | 52.200 | 0,09% | Opção de compra |
| Virtus Investment Advisers, LLC | $1.328.566 | 50.825 | 0,09% | Ações |
| ENVESTNET ASSET MANAGEMENT INC | $1.272.365 | 48.675 | 0,08% | Ações |
| Quantinno Capital Management LP | $1.245.362 | 47.642 | 0,08% | Ações |
| WELLS FARGO & COMPANY/MN | $1.122.164 | 42.929 | 0,07% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $1.111.577 | 42.524 | 0,07% | Ações |
| Bank of New York Mellon Corp | $1.076.785 | 41.193 | 0,07% | Ações |
| MARSHALL WACE, LLP | $1.070.380 | 40.948 | 0,07% | Ações |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.033.419 | 39.534 | 0,07% | Ações |
| Aquilo Capital Management, LLC | $1.006.181 | 84.482 | 0,07% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $965.141 | 36.922 | 0,06% | Ações |
| TUDOR INVESTMENT CORP ET AL | $953.352 | 36.471 | 0,06% | Ações |
| HighTower Advisors, LLC | $943.654 | 36.100 | 0,06% | Ações |
| Persistent Asset Partners Ltd | $939.341 | 35.935 | 0,06% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $936.221 | 37.389 | 0,06% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $904.653 | 34.608 | 0,06% | Ações |
| HighVista Strategies LLC | $889.100 | 34.013 | 0,06% | Ações |
| COMMONWEALTH EQUITY SERVICES, LLC | $837.838 | 32.052 | 0,05% | Ações |
| TWO SIGMA ADVISERS, LP | $827.157 | 31.415 | 0,05% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $807.360 | 30.886 | 0,05% | Ações |
| SBI Okasan Asset Management Co.Ltd. | $771.200 | 32.000 | 0,05% | Ações |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $735.529 | 27.935 | 0,05% | Ações |
| MetLife Investment Management, LLC | $728.888 | 27.884 | 0,05% | Ações |
| JOURNEY STRATEGIC WEALTH LLC | $722.304 | 28.846 | 0,05% | Ações |
| STRS OHIO | $692.710 | 26.500 | 0,05% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $686.933 | 26.279 | 0,04% | Ações |
| Brevan Howard Capital Management LP | $678.490 | 25.956 | 0,04% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $657.735 | 25.162 | 0,04% | Ações |
| RITHOLTZ WEALTH MANAGEMENT | $633.712 | 24.243 | 0,04% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $607.206 | 23.229 | 0,04% | Ações |
| Duncan Williams Asset Management, LLC | $577.563 | 22.095 | 0,04% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $564.049 | 21.578 | 0,04% | Ações |
| BARCLAYS PLC | $524.577 | 20.068 | 0,03% | Ações |
| SIMPLEX TRADING, LLC | $507.926 | 19.431 | 0,03% | Ações |
| Invesco Ltd. | $491.720 | 18.811 | 0,03% | Ações |
Executivos da empresa 28 insiders · 12 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Kenneth Galbraith | Chair & CEO | 12 de Janeiro de 2026 A | 226.842 | 0 | 4 | $-3.337.929 |
| Kristin Stafford | EVP, Chief Financial Officer | 6 de Abril de 2026 A | — | 0 | 0 | $0 |
| Christopher Astle | SVP & Chief Financial Officer | 5 de Janeiro de 2024 A | 6.503 | 0 | 0 | $0 |
| Neil A Klompas | President & COO | 10 de Março de 2023 M | 17.032 | 0 | 0 | $0 |
| Mark Hollywood | EVP & Chief Operating Officer | 6 de Julho de 2026 A | 133.852 | 0 | 1 | $-138.740 |
| Paul R Schneider | EVP, General Counsel | 13 de Maio de 2026 A | — | 0 | 0 | $0 |
| Adam Schayowitz | EVP, Head of Research & Development | 9 de Abril de 2026 A | — | 0 | 0 | $0 |
| Scott Platshon | EVP, Chief Business Officer | 9 de Abril de 2026 A | — | 0 | 0 | $0 |
| Paul Andrew Moore | Chief Scientific Officer | 12 de Janeiro de 2026 A | 48.497 | 0 | 3 | $-721.486 |
| Jeffrey T L Smith | EVP & Chief Medical Officer | 12 de Janeiro de 2026 M | 26.708 | 0 | 2 | $-475.562 |
| Leone D Patterson | EVP, Chief Bus & Fin Officer | 6 de Janeiro de 2026 A | 459 | 0 | 0 | $0 |
| Neil Josephson | Chief Medical Officer | 10 de Novembro de 2022 M | 14.449 | 0 | 0 | $0 |
| Gregory A. Ciongoli | Conselheiro | 12 de Janeiro de 2026 A | 488.500 | 0 | 0 | $0 |
| Alessandra Cesano | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Carlos Campoy | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Robert E Landry | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Kelvin Neu | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Brian N Cherry | Conselheiro | 12 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| EcoR1 Capital, LLC | Conselheiro | 17 de Janeiro de 2025 P | 15.720.161 | 0 | 0 | $0 |
| Nancy Davidson | Conselheiro | 10 de Dezembro de 2024 A | — | 0 | 0 | $0 |
| Neil Gallagher | Conselheiro | 10 de Dezembro de 2024 A | — | 0 | 0 | $0 |
| Derek John Michael Miller | Conselheiro | 10 de Dezembro de 2024 A | — | 0 | 0 | $0 |
| Troy Cox | Conselheiro | 10 de Dezembro de 2024 A | — | 0 | 0 | $0 |
| Kenneth J. Hillan | Conselheiro | 7 de Dezembro de 2023 A | — | 0 | 0 | $0 |
| Hollings Renton | Conselheiro | 7 de Dezembro de 2023 A | — | 0 | 0 | $0 |
| Natalie Sacks | Conselheiro | 21 de Dezembro de 2022 A | — | 0 | 0 | $0 |
| Lota S. Zoth | Conselheiro | 21 de Dezembro de 2022 A | — | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC, Oleg Nodelman, EcoR1 Capital Fund Qualified, L.P. ×8 declarações | 19 de Novembro de 2025 | 30,70% | Emenda | Campanha no conselho | SEC |
| All Blue Falcons FZE, Daniel Edward Llewellen Cookson ×2 declarações | 28 de Dezembro de 2022 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 42 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 1,51% | 105.615 NS | 31 de Maio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,80% | 10.832 NS | 30 de Abril de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,49% | 186.247 NS | 30 de Abril de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,25% | 110.902 NS | 30 de Abril de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,15% | 16.669 NS | 31 de Maio de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 17.393 NS | 30 de Abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2.766 NS | 31 de Maio de 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,09% | 80.480 NS | 30 de Junho de 2026 | N-PORT |
| RSSL · Global X Funds | 0,04% | 21.639 NS | 30 de Abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 189.866 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 2.345 NS | 31 de Maio de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 10.887 NS | 31 de Maio de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 1.834 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 16.794 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1.855 NS | 31 de Maio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 5.236 NS | 30 de Abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.925 NS | 31 de Maio de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 26.839 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 47 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5.213 NS | 30 de Abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 72.902 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.951 NS | 30 de Abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 8.364 NS | 30 de Abril de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 130 NS | 30 de Abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 de Julho de 2026 | Diário |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| IWV · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| IWO · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| IWM · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| IBB · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23 de Julho de 2026 | Diário |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 de Julho de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | — | — | 20 de Julho de 2026 | Diário |
| ISCB · iShares Trust | — | — | 4 de Agosto de 2026 | Diário |
| ISCG · iShares Trust | — | — | 4 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | — | — | 4 de Agosto de 2026 | Diário |
| SMMV · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| WSML · iShares Trust | — | — | 4 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 de Julho de 2026 | Diário |